您的位置: 首页 > 2024年11月 第55卷 第11期 > 文字全文
2023年7月 第38卷 第7期11
目录

核磁弥散成像及ADC值在肝内非肿瘤性病变诊断与鉴别诊断中的价值

The value of diffusion weighted imaging and ADC value in the diagnosis and differential diagnosis of non neoplastic liver lesions

来源期刊: 广州医药 | 1303-1307 发布时间:2024-12-02 收稿时间:2025/11/13 18:43:16 阅读量:28
作者:
关键词:
核磁弥散成像肝内非肿瘤性病变图像质量信号特征表观弥散系数灵敏度特异度
magnetic resonance diffusion imagingnon tumor lesions in the liverimage qualitysignal characteristicsapparent dispersion coefficientsensitivityspecificity
DOI:
10.20223/j.cnki.1000-8535.2024.11.010
收稿时间:
2024-03-01 
修订日期:
 
接收日期:
 
引用总数:
1  
目的 探讨与分析核磁弥散成像(DWI)及表观弥散系数(ADC)值在肝内非肿瘤性病变诊断与鉴别诊断中的价值。方法 选择2020年8月—2023年5月厦门大学附属第一医院收治的120例肝脏占位性病变患者为研究对象,所有患者均给予常规MRI与DWI,记录图像质量、信号特征,计算ADC值,评价诊断效能。结果 120例患者中,病理诊断为肝内非肿瘤性病变70例(非肿瘤组:肝脓肿32例、肝囊肿28例、肝炎性假瘤10例),肝内肿瘤性病变50例(肿瘤组:肝血管瘤38例,肝癌12例)。非肿瘤组与肿瘤组的图像质量优良率分别为94.29%(66/70)与88.00%(44/50),组间比较差异无统计学意义(χ2=1.509,P>0.05)。非肿瘤组的磁共振信号特征多为高信号(62.86%),肿瘤组多为低信号(60.00%),两组比较差异有统计学意义(χ2=45.691,P<0.05)。在b值为400 s/mm2和800 s/mm2条件下,非肿瘤组的ADC值(0.84±0.17、0.77±0.14)均低于肿瘤组(1.29±0.24、1.19±0.34),差异有统计学意义(t=12.029、9.302,P<0.05)。DWI判断为肝内非肿瘤性病变68例,DWI在肝内非肿瘤性病变的鉴别诊断灵敏度与特异度分别为95.71%(67/70)和98.00%(49/50),ROC曲线显示DWI在肝内非肿瘤性病变的诊断曲线下面积为0.895。结论 DWI在肝内非肿瘤性病变中的图像显示质量高,可通过信号特征与ADC判断病灶状况,对鉴别肝内非肿瘤性病变具有较高的诊断效能。
Objective To investigate and analyze the value of diffusion weighted imaging(DWI)and apparent diffusion coefficient(ADC)in the diagnosis and differential diagnosis of non neoplastic liver lesions.Methods A total of 120 patients with liver focal lesions admitted to the First Affiliated Hospital of Xiamen University from August 2020 to may 2023 were selected.All patients were given conventional MRI and DWI,the image quality and signal characteristics were recorded,the ADC value was calculated,and the diagnostic efficiency was evaluated.Results Among the 120 patients,70 cases were pathologically diagnosed as non neoplastic lesions(non tumor group,32 cases of liver abscess,28 cases of liver cyst,10 cases of hepatitis pseudotumor),and 50 cases were neoplastic lesions(tumor group,38 cases of hepatic hemangioma,12 cases of liver cancer).The excellent and good image quality rates of non tumor group and tumor group were 94.29%(66/70)and 88.00%(44/50),respectively,and there was no significant difference between the two groups(χ2=1.509,P>0.05).The MRI signal characteristics of non tumor group were mostly high signal(62.86%),while the tumor group were mostly low signal(60.00%),and the difference between the two groups was statistically significant(χ2=45.691,P<0.05).When the b value was 400 s/mm2 and 800 s/mm2,the ADC value of non tumor group(0.84±0.17,0.77±0.14)was significantly lower than that of tumor group.The difference was statistically significant(t=12.029,9.302,P<0.05).Sixty-eight patients were diagnosed as non neoplastic lesions by DWI.The sensitivity and specificity of DWI in the differential diagnosis of non neoplastic lesions were 95.71%(67/70)and 98.00%(49/50),respectively.The ROC curve shows that the area under the diagnostic curve of DWI for non tumor lesions in the liver was 0.895.Conclusion sDWI has high image quality in the diagnosis of non neoplastic lesions in the liver.Doctors can judge the status of lesions by signal characteristics and ADC,which has high diagnostic efficiency in the identification of non neoplastic lesions in the liver.
1、 ICHIKAWA S,MORISAKA H,OMIYA Y,et al.Distinction between hepatocellular carcinoma and hypervascular liver metastases in non-cirrhotic patients using gadoxetate disodium-enhanced magnetic resonance imaging[J].Can Assoc Radiol J,2022,73(4):639-646. ICHIKAWA S,MORISAKA H,OMIYA Y,et al.Distinction between hepatocellular carcinoma and hypervascular liver metastases in non-cirrhotic patients using gadoxetate disodium-enhanced magnetic resonance imaging[J].Can Assoc Radiol J,2022,73(4):639-646.
2、 方楠,郑露,齐斌,等.MRI弥散加权成像在鼻咽癌诊断中的应用[J].国际医药卫生导报,2021,27(18):2811-2815. 方楠,郑露,齐斌,等.MRI弥散加权成像在鼻咽癌诊断中的应用[J].国际医药卫生导报,2021,27(18):2811-2815.
3、 ERDEN A,KURU Z D,AD?GüZEL M,et al.Quantitative liver magnetic resonance imaging:correlation between conventional magnetic resonance imaging,laboratory values,and prognostic indices in Budd-Chiari syndrome[J].Diagn Interv Radiol,2023,29(3):428-436. ERDEN A,KURU Z D,AD?GüZEL M,et al.Quantitative liver magnetic resonance imaging:correlation between conventional magnetic resonance imaging,laboratory values,and prognostic indices in Budd-Chiari syndrome[J].Diagn Interv Radiol,2023,29(3):428-436.
4、 DO?AN G M,SI?IRCI A,OKUT G,et al.The magnetic resonance imaging assessment of optic nerve sheath diameter in pediatric acute liver failure patients[J].Eur Rev Med Pharmacol Sci,2022,26(3):853-859. DO?AN G M,SI?IRCI A,OKUT G,et al.The magnetic resonance imaging assessment of optic nerve sheath diameter in pediatric acute liver failure patients[J].Eur Rev Med Pharmacol Sci,2022,26(3):853-859.
5、 刘晓伟,王婷婷,温辉,等.肝脏炎性肌纤维母细胞瘤病理特点及CT、MRI影像征象分析[J].中国CT和MRI杂志,2022,(2):84-86. 刘晓伟,王婷婷,温辉,等.肝脏炎性肌纤维母细胞瘤病理特点及CT、MRI影像征象分析[J].中国CT和MRI杂志,2022,(2):84-86.
6、 彭婧,谢勇.核磁共振全身弥散加权成像技术在恶性肿瘤分期中的应用价值[J].中国实用医药,2021,16(28):91-93. 彭婧,谢勇.核磁共振全身弥散加权成像技术在恶性肿瘤分期中的应用价值[J].中国实用医药,2021,16(28):91-93.
7、 CHEN Y,LI B,JIANG Z,et al.Multi-parameter diffusion and perfusion magnetic resonance imaging and radiomics nomogram for preoperative evaluation of aquaporin-1 expression in rectal cancer[J].Abdom Radiol(NY),2022,47(4):1276-1290. CHEN Y,LI B,JIANG Z,et al.Multi-parameter diffusion and perfusion magnetic resonance imaging and radiomics nomogram for preoperative evaluation of aquaporin-1 expression in rectal cancer[J].Abdom Radiol(NY),2022,47(4):1276-1290.
8、 牟仁琪,王春业,兰受昌,等.MRI联合CT诊断混合型肝脏血管平滑肌脂肪瘤的临床价值[J].国际医药卫生导报,2023,29(7):929-931. 牟仁琪,王春业,兰受昌,等.MRI联合CT诊断混合型肝脏血管平滑肌脂肪瘤的临床价值[J].国际医药卫生导报,2023,29(7):929-931.
9、 CALISTRI L,MARAGHELLI D,NARDI C,et al.Magnetic resonance imaging of inflammatory pseudotumor of the liver:A 2021 systematic literature update and series presentation[J].Abdom Radiol(NY),2022,47(8):2795-2810. CALISTRI L,MARAGHELLI D,NARDI C,et al.Magnetic resonance imaging of inflammatory pseudotumor of the liver:A 2021 systematic literature update and series presentation[J].Abdom Radiol(NY),2022,47(8):2795-2810.
10、 吴建刚,雷雪梅,马清明.Gd-EOB-DTPA增强MRI与增强CT诊断原发性肝癌价值比较[J].中国CT和MRI杂志,2021,19(9):100-101,134. 吴建刚,雷雪梅,马清明.Gd-EOB-DTPA增强MRI与增强CT诊断原发性肝癌价值比较[J].中国CT和MRI杂志,2021,19(9):100-101,134.
11、 赵空军,何承勇.单光子发射计算机断层成像术/CT与核磁共振成像对肝肿瘤良恶性的诊断价值[J].中国肿瘤临床与康复,2021,28(12):1469-1472. 赵空军,何承勇.单光子发射计算机断层成像术/CT与核磁共振成像对肝肿瘤良恶性的诊断价值[J].中国肿瘤临床与康复,2021,28(12):1469-1472.
12、 袁海军,曾茗.MRI联合DWI和DCE序列对脂肪肝背景下局灶结节性病变的诊断价值分析[J].医学临床研究,2023,40(1):41-44. 袁海军,曾茗.MRI联合DWI和DCE序列对脂肪肝背景下局灶结节性病变的诊断价值分析[J].医学临床研究,2023,40(1):41-44.
13、 蔡彩云,刘建成,陈文锦,等.肿瘤标志物联合多b值DWI MR多期动态增强成像对肝脏肿瘤的诊断价值[J].中国现代医生,2020,58(29):125-128. 蔡彩云,刘建成,陈文锦,等.肿瘤标志物联合多b值DWI MR多期动态增强成像对肝脏肿瘤的诊断价值[J].中国现代医生,2020,58(29):125-128.
14、 郭小芳,王凌云,吕天宝.CT扫描结合MRI在原发性肝癌诊断与介入治疗预后评估中的临床意义[J].广州医药,2022,53(1):58-61. 郭小芳,王凌云,吕天宝.CT扫描结合MRI在原发性肝癌诊断与介入治疗预后评估中的临床意义[J].广州医药,2022,53(1):58-61.
15、 MORADI B,GHORBANI Z,SHIRAZI M,et al.Comparison of fetal lung maturation in fetuses with intrauterine growth restriction with control group,using lung volume,lung/liver and lung/muscle signal intensity and apparent diffusion coefficient ratios on different magnetic resonance imaging sequences[J].J Matern Fetal Neonatal Med,2022,35(25):8936-8944. MORADI B,GHORBANI Z,SHIRAZI M,et al.Comparison of fetal lung maturation in fetuses with intrauterine growth restriction with control group,using lung volume,lung/liver and lung/muscle signal intensity and apparent diffusion coefficient ratios on different magnetic resonance imaging sequences[J].J Matern Fetal Neonatal Med,2022,35(25):8936-8944.
16、 杨洁,李秋实,赵森,等.MRI动态增强扫描在肝癌诊断、病理分级评估中的应用观察[J].中国CT和MRI杂志,2023,21(6):100-102. 杨洁,李秋实,赵森,等.MRI动态增强扫描在肝癌诊断、病理分级评估中的应用观察[J].中国CT和MRI杂志,2023,21(6):100-102.
17、 SERAFINI A,RUGGERI V,INCHINGOLO R,et al.Liver magnetic resonance imaging for evaluation of response to treatment after stereotactic body radiation therapy of hepatocellular carcinoma[J].World J Hepatol,2022,14(9):1790-1803. SERAFINI A,RUGGERI V,INCHINGOLO R,et al.Liver magnetic resonance imaging for evaluation of response to treatment after stereotactic body radiation therapy of hepatocellular carcinoma[J].World J Hepatol,2022,14(9):1790-1803.
18、 刘显旺,韩引萍,李昇霖,等.影像组学在肝脏非肿瘤性病变中的研究进展[J].临床放射学杂志,2022,41(1):199-202. 刘显旺,韩引萍,李昇霖,等.影像组学在肝脏非肿瘤性病变中的研究进展[J].临床放射学杂志,2022,41(1):199-202.
19、 周元龙,李思柔,郭岩松,等.1例原发性肝脏神经内分泌肿瘤的诊断[J].山东医药,2023,63(3):81-83. 周元龙,李思柔,郭岩松,等.1例原发性肝脏神经内分泌肿瘤的诊断[J].山东医药,2023,63(3):81-83.
20、 王志鹏,郭亚楠,张仙虎,等.基于磁共振图像比较LI-RADS 2018版与2017版的诊断效果[J].医学影像学杂志,2023,33(6):1029-1034. 王志鹏,郭亚楠,张仙虎,等.基于磁共振图像比较LI-RADS 2018版与2017版的诊断效果[J].医学影像学杂志,2023,33(6):1029-1034.
1、刘旭红,张乾营,丁碧娇,等.超分辨深度学习模型优化小肝癌磁共振扩散加权成像质量[J].分子影像学杂志,2025,48(11):1358-1363. 刘旭红,张乾营,丁碧娇,等.超分辨深度学习模型优化小肝癌磁共振扩散加权成像质量[J].分子影像学杂志,2025,48(11):1358-1363.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录